Medullary thyroid carcinoma
ML Griebeler, H Gharib, GB Thompson - Endocrine Practice, 2013 - Elsevier
Objective This review outlines advances in the diagnosis, genetic testing, and progress in
medullary thyroid cancer (MTC) treatment in light of the most recent evidence. Methods …
medullary thyroid cancer (MTC) treatment in light of the most recent evidence. Methods …
[PDF][PDF] Medullary thyroid cancer–feature review and update on systemic treatment
Medullary thyroid carcinoma (MTC) is a rare malignancy that originates from parafollicular
(C cells) of the thyroid and accounts for 2-4% of all thyroid malignancies. MTC may be …
(C cells) of the thyroid and accounts for 2-4% of all thyroid malignancies. MTC may be …
Medullary thyroid carcinoma: recent advances and management update
DJ Marsh, DL Learoyd, BG Robinson - Thyroid, 1995 - liebertpub.com
Medullary thyroid carcinoma (MTC) is a malignancy of the thyroid C-cells that comprises 5–
10% of all thyroid cancers. MTC occurs in both sporadic and familial forms, the latter making …
10% of all thyroid cancers. MTC occurs in both sporadic and familial forms, the latter making …
Medullary thyroid cancer
YN You, V Lakhani, SA Wells… - Surgical Oncology …, 2006 - surgonc.theclinics.com
Medullary thyroid carcinoma (MTC) is a prototype disease in the rapidly emerging field of
molecular endocrine oncology. Since its recognition in 1959, MTC has distinguished itself …
molecular endocrine oncology. Since its recognition in 1959, MTC has distinguished itself …
Current diagnosis and management of medullary thyroid carcinoma
D Giuffrida, H Gharib - Annals of Oncology, 1998 - Elsevier
Background Medullary thyroid carcinoma (MTC) originates in the thyroid C cells, accounting
for 5% to 10% or all thyroid malignancies. Approximately 75% of cases are sporadic …
for 5% to 10% or all thyroid malignancies. Approximately 75% of cases are sporadic …
Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives
L Ceolin, MA da Silveira Duval… - Endocrine-related …, 2019 - erc.bioscientifica.com
Medullary thyroid carcinoma (MTC) is a rare type of tumor that originates from thyroid C cells
and accounts for 2–4% of all malignant thyroid neoplasms. MTC may occur sporadically or …
and accounts for 2–4% of all malignant thyroid neoplasms. MTC may occur sporadically or …
Medullary thyroid cancer: medical management and follow-up
A Traugott, JF Moley - Current Treatment Options in Oncology, 2005 - Springer
Opinion statement Medullary thyroid carcinoma (MTC) is a neuroendocrine malignancy that
occurs in hereditary (25%) and sporadic (75%) clinical settings. MTC is present in all …
occurs in hereditary (25%) and sporadic (75%) clinical settings. MTC is present in all …
Advances and controversies in the diagnosis and management of medullary thyroid carcinoma
HM Heshmati, H Gharib, JA van Heerden… - The American journal of …, 1997 - Elsevier
Recent advances in the diagnosis and treatment of medullary thyroid carcinoma (MTC) have
been significant, but some issues remain controversial. MTC may occur either as a …
been significant, but some issues remain controversial. MTC may occur either as a …
Medullary thyroid carcinoma
JF Moley - Current treatment options in oncology, 2003 - Springer
Opinion statement Medullary thyroid carcinoma (MTC) is a neuroendocrine malignancy that
occurs in hereditary (25%) and sporadic (75%) clinical settings. MTC is present in all …
occurs in hereditary (25%) and sporadic (75%) clinical settings. MTC is present in all …
Medullary thyroid carcinoma: multivariate analysis of prognostic factors influencing survival
IP Callejo, JA Brito, CM Zagalo, JR Santos - Clinical and Translational …, 2006 - Springer
Background Medullary thyroid carcinoma (MTC) is a rare development of thyroid cancer with
a no negligible mortality rate. Our aim was to determine factors that predict outcome in …
a no negligible mortality rate. Our aim was to determine factors that predict outcome in …